Related Experiment Video
Updated: Jun 12, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
The cytologic criteria of malignancy
Andrew H Fischer1, Chengquan Zhao, Qing Kay Li
1Department of Pathology, Rm 213 Biotech 3, 1 Innovation Dr., University of Massachusetts, Worcester, Massachusetts 01605, USA. andrew.fischer@umassmemorial.org
Cytology and cell biology can bridge the gap in understanding cancer by exploring the molecular basis of "criteria of malignancy." This research classifies these criteria, offering a new framework for cancer research and diagnosis.
Area of Science:
- Oncology
- Cell Biology
- Cytopathology
Background:
- Cancer diagnosis relies on morphology, yet the molecular underpinnings of these features remain largely unknown.
- Cytology employs minimal biopsy techniques, focusing on the smallest scale "criteria of malignancy" for diagnosis.
Purpose of the Study:
- To classify "criteria of malignancy" and examine their relationship with current cell biology concepts.
- To establish common ground between cytologists and cell biologists in cancer research.
Main Methods:
- Classification of "criteria of malignancy" into distinct groups based on observed alterations.
- Review of these criteria in the context of established cell biology principles and molecular mechanisms.
Main Results:
- Criteria were categorized into three groups: tissue-level alterations (Group 1), genetic instability (Group 2), and subcellular changes (Group 3).
- Group 1 relates to anoikis resistance, cell adhesion, and polarity loss; Group 2 involves chromosomal and epigenetic instability; Group 3 includes unexplained subcellular changes.
- Some Group 3 criteria are linked to cancer genes but lack clear structural basis.
Conclusions:
- The "criteria of malignancy" offer a biologically relevant framework distinct from histogenetic classification, fostering interdisciplinary collaboration.
- Molecular understanding of these criteria is crucial for improving cancer diagnosis and uncovering novel cellular physiologies.
Related Concept Videos
Cancer
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancers Originate from Somatic Mutations in a Single Cell
Cellular Adaptation IV: Dysplasia and Metaplasia
Abnormal Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

